Ozercan IH - Search Results

1

Isthmin-1 and spexin as promising novel biomarker candidates for invasive ductal breast carcinoma.

Turk A, Metin TO, Kuloglu T, Yilmaz M, Artas G, Ozercan IH, Hancer S. Turk A, et al. Among authors: ozercan ih. Tissue Cell. 2024 Dec;91:102601. doi: 10.1016/j.tice.2024.102601. Epub 2024 Nov 2. Tissue Cell. 2024. PMID: 39520846

2

Asprosin and meteorin-like protein immunoreactivity in invasive ductal breast carcinoma stages.

Akkus G, Koyuturk LC, Yilmaz M, Hancer S, Ozercan IH, Kuloglu T. Akkus G, et al. Among authors: ozercan ih. Tissue Cell. 2022 Aug;77:101855. doi: 10.1016/j.tice.2022.101855. Epub 2022 Jun 17. Tissue Cell. 2022. PMID: 35749857

3

Immunostaining characteristics of irisin in benign and malignant renal cancers.

Kuloğlu T, Artaş G, Yardim M, Sahin I, Aydin Y, Beyoğlu N, Özercan IH, Yalcin MH, Ugur K, Aydin S. Kuloğlu T, et al. Among authors: ozercan ih. Biotech Histochem. 2019 Aug;94(6):435-441. doi: 10.1080/10520295.2019.1586998. Epub 2019 Mar 21. Biotech Histochem. 2019. PMID: 30896263

4

The combined effect of pomegranate extract and tangeretin on the DMBA-induced breast cancer model.

Gul HF, Ilhan N, Ilhan N, Ozercan IH, Kuloglu T. Gul HF, et al. Among authors: ozercan ih. J Nutr Biochem. 2021 Mar;89:108566. doi: 10.1016/j.jnutbio.2020.108566. Epub 2020 Dec 14. J Nutr Biochem. 2021. PMID: 33326843

5

Irisin immunohistochemistry in gastrointestinal system cancers.

Aydin S, Kuloglu T, Ozercan MR, Albayrak S, Aydin S, Bakal U, Yilmaz M, Kalayci M, Yardim M, Sarac M, Kazez A, Kocdor H, Kanat B, Ozercan İH, Gonen M, Bilgen M, Balgetir F. Aydin S, et al. Among authors: ozercan mr, ozercan ih. Biotech Histochem. 2016;91(4):242-50. doi: 10.3109/10520295.2015.1136988. Epub 2016 Mar 10. Biotech Histochem. 2016. PMID: 26963139

6

Comparison of the therapeutic effects of sildenafil citrate, heparin and neuropeptides in a rat model of acetic acid-induced gastric ulcer.

Kalayci M, Kocdor MA, Kuloglu T, Sahin İ, Sarac M, Aksoy A, Yardim M, Dalkilic S, Gursu O, Aydin S, Akkoc RF, Ugras M, Artas G, Ozercan İH, Ugur K, Aydin S. Kalayci M, et al. Among authors: ozercan ih. Life Sci. 2017 Oct 1;186:102-110. doi: 10.1016/j.lfs.2017.08.013. Epub 2017 Aug 12. Life Sci. 2017. PMID: 28807720

7

Prognostic Value of TRPM7 Expression and Factor XIIIa-Expressing Tumor-Associated Macrophages in Gastric Cancer.

Calik M, Calik I, Artas G, Ozercan IH. Calik M, et al. Among authors: ozercan ih. Gastroenterol Res Pract. 2021 Dec 13;2021:7249726. doi: 10.1155/2021/7249726. eCollection 2021. Gastroenterol Res Pract. 2021. PMID: 34938330 Free PMC article.

8

The increased expression of Piezo1 and Piezo2 ion channels in human and mouse bladder carcinoma.

Etem EÖ, Ceylan GG, Özaydın S, Ceylan C, Özercan I, Kuloğlu T. Etem EÖ, et al. Adv Clin Exp Med. 2018 Aug;27(8):1025-1031. doi: 10.17219/acem/71080. Adv Clin Exp Med. 2018. PMID: 30010255 Free article.

9

TRPM2 mediates distruption of autophagy machinery and correlates with the grade level in prostate cancer.

Tektemur A, Ozaydin S, Etem Onalan E, Kaya N, Kuloglu T, Ozercan İH, Tekin S, Elyas HM. Tektemur A, et al. Among authors: ozercan ih. J Cancer Res Clin Oncol. 2019 May;145(5):1297-1311. doi: 10.1007/s00432-019-02898-z. Epub 2019 Mar 19. J Cancer Res Clin Oncol. 2019. PMID: 30888515

10

Neuroprotective and antioxidant effects of ghrelin in an experimental glaucoma model.

Can N, Catak O, Turgut B, Demir T, Ilhan N, Kuloglu T, Ozercan IH. Can N, et al. Among authors: ozercan ih. Drug Des Devel Ther. 2015 Jun 2;9:2819-29. doi: 10.2147/DDDT.S83067. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26082612 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters